Skip to main content
Erschienen in: Pediatric Nephrology 1/2020

20.09.2019 | Clinical Quiz

A rare cause of hypertension in childhood: Answers

verfasst von: Nuran Kucuk, Zehra Yavas Abalı, Saygın Abalı, Nur Canpolat, Gozde Yesil, Serap Turan, Abdullah Bereket, Tulay Guran

Erschienen in: Pediatric Nephrology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

1.
What is the most likely diagnosis of our patients with hypokalemic metabolic alkalosis and low renin hypertension (LRH)?
 
Literatur
1.
Zurück zum Zitat Monticone S, Losano I, Tetti M, Buffolo F, Veglio F, Mulatero P (2018) Diagnostic approach to low-renin hypertension. Clin Endocrinol 89:385–396CrossRef Monticone S, Losano I, Tetti M, Buffolo F, Veglio F, Mulatero P (2018) Diagnostic approach to low-renin hypertension. Clin Endocrinol 89:385–396CrossRef
2.
Zurück zum Zitat Al-Harbi T, Al-Shaikh A (2012) Apparent mineralocorticoid excess syndrome: report of one family with three affected children. J Pediatr Endocrinol Metab 25:1083–1088CrossRef Al-Harbi T, Al-Shaikh A (2012) Apparent mineralocorticoid excess syndrome: report of one family with three affected children. J Pediatr Endocrinol Metab 25:1083–1088CrossRef
3.
Zurück zum Zitat Razzaghy-Azar M, Yau M, Khattab A, New MI (2017) Apparent mineralocorticoid excess and the long term treatment of genetic hypertension. J Steroid Biochem Mol Biol 165:145–150CrossRef Razzaghy-Azar M, Yau M, Khattab A, New MI (2017) Apparent mineralocorticoid excess and the long term treatment of genetic hypertension. J Steroid Biochem Mol Biol 165:145–150CrossRef
4.
Zurück zum Zitat Yau M, Haider S, Khattab A, Ling C, Mathew M, Zaidi S, Bloch M, Patel M, Ewert S, Abdullah W, Toygar A, Mudryi V, Al Badi M, Alzubdi M, Wilson RC, Al Azkawi HS, Ozdemir HN, Abu-Amer W, Hertecant J, Razzaghy-Azar M, Funder JW, Al Senani A, Sun L, Kim SM, Yuen T, Zaidi M, New MI (2017) Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency. Proc Natl Acad Sci U S A 114:11248–11256CrossRef Yau M, Haider S, Khattab A, Ling C, Mathew M, Zaidi S, Bloch M, Patel M, Ewert S, Abdullah W, Toygar A, Mudryi V, Al Badi M, Alzubdi M, Wilson RC, Al Azkawi HS, Ozdemir HN, Abu-Amer W, Hertecant J, Razzaghy-Azar M, Funder JW, Al Senani A, Sun L, Kim SM, Yuen T, Zaidi M, New MI (2017) Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency. Proc Natl Acad Sci U S A 114:11248–11256CrossRef
5.
Zurück zum Zitat Funder JW, Pearce PT, Smith R, Smith AI (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583–585CrossRef Funder JW, Pearce PT, Smith R, Smith AI (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583–585CrossRef
6.
Zurück zum Zitat Funder JW (2007) Why are mineralocorticoid receptors so nonselective? Curr Hypertens Rep 9:112–116CrossRef Funder JW (2007) Why are mineralocorticoid receptors so nonselective? Curr Hypertens Rep 9:112–116CrossRef
7.
Zurück zum Zitat Dave-Sharma S, Wilson RC, Harbison MD, Newfield R, Azar MR, Krozwski ZS, Funder JW, Shackleton CH, Bradlow HL, Wei JQ, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Akkurt HI, De Santis C, New MI (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 83:2244–2254PubMed Dave-Sharma S, Wilson RC, Harbison MD, Newfield R, Azar MR, Krozwski ZS, Funder JW, Shackleton CH, Bradlow HL, Wei JQ, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Akkurt HI, De Santis C, New MI (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 83:2244–2254PubMed
8.
Zurück zum Zitat Werder E, Zachmann M, Vollmin JA, Veyrat R, Prader A (1974) Unusual steroid excretion in a child with low renin hypertension. Res Steroids 6:385–389 Werder E, Zachmann M, Vollmin JA, Veyrat R, Prader A (1974) Unusual steroid excretion in a child with low renin hypertension. Res Steroids 6:385–389
9.
Zurück zum Zitat New MI, Levine S, Biglieri EG, Pareira J, Ulick S (1977) Evidence for an unidentified steroid in a child with apparent mineralocortioid hypertension. J Clin Endocrinol Metab 44:924–933CrossRef New MI, Levine S, Biglieri EG, Pareira J, Ulick S (1977) Evidence for an unidentified steroid in a child with apparent mineralocortioid hypertension. J Clin Endocrinol Metab 44:924–933CrossRef
10.
Zurück zum Zitat Ulick S, Ramirez LC, New MI (1977) An abnormality in steroid reductive metabolism in a hypertensive syndrome. J Clin Endocrinol Metab 44:799–802CrossRef Ulick S, Ramirez LC, New MI (1977) An abnormality in steroid reductive metabolism in a hypertensive syndrome. J Clin Endocrinol Metab 44:799–802CrossRef
11.
Zurück zum Zitat Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CH, Funder JW, New MI (1995) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263–2266PubMed Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CH, Funder JW, New MI (1995) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263–2266PubMed
12.
Zurück zum Zitat Baudrand R, Vaidya A (2018) The low-renin hypertension phenotype: genetics and the role of the mineralocorticoid receptor. Int J Mol Sci 11:19 Baudrand R, Vaidya A (2018) The low-renin hypertension phenotype: genetics and the role of the mineralocorticoid receptor. Int J Mol Sci 11:19
13.
Zurück zum Zitat Breiderhoff T, Himmerkus N, Stuiver M, Mutig K, Will C, Meij IC, Bachmann S, Bleich M, Willnow TE, Müller D (2012) Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosis. Proc Natl Acad Sci U S A 109:14241–14246CrossRef Breiderhoff T, Himmerkus N, Stuiver M, Mutig K, Will C, Meij IC, Bachmann S, Bleich M, Willnow TE, Müller D (2012) Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosis. Proc Natl Acad Sci U S A 109:14241–14246CrossRef
14.
Zurück zum Zitat Meyers N, Nelson-Williams C, Malaga-Dieguez L, Kaufmann H, Loring E, Knight J, Lifton RP, Trachtman H (2019) Hypokalemia associated with a Claudin 10 mutation: a case report. Am J Kidney Dis 73:425–428CrossRef Meyers N, Nelson-Williams C, Malaga-Dieguez L, Kaufmann H, Loring E, Knight J, Lifton RP, Trachtman H (2019) Hypokalemia associated with a Claudin 10 mutation: a case report. Am J Kidney Dis 73:425–428CrossRef
15.
Zurück zum Zitat Rogers SL, Hughes BA, Jones CA, Freedman L, Smart K, Taylor N, Stewart PM, Shackleton CH, Krone NP, Blissett J, Tomlinson JW (2014) Diminished 11β-hydroxysteroid dehydrogenase type 2 activity is associated with decreased weight and weight gain across the first year of life. J Clin Endocrinol Metab 99:821–831CrossRef Rogers SL, Hughes BA, Jones CA, Freedman L, Smart K, Taylor N, Stewart PM, Shackleton CH, Krone NP, Blissett J, Tomlinson JW (2014) Diminished 11β-hydroxysteroid dehydrogenase type 2 activity is associated with decreased weight and weight gain across the first year of life. J Clin Endocrinol Metab 99:821–831CrossRef
16.
Zurück zum Zitat Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN (2017) The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 136:665–767CrossRef Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN (2017) The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 136:665–767CrossRef
17.
Zurück zum Zitat Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC, Whorwood CB (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet 347:88–91CrossRef Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC, Whorwood CB (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet 347:88–91CrossRef
Metadaten
Titel
A rare cause of hypertension in childhood: Answers
verfasst von
Nuran Kucuk
Zehra Yavas Abalı
Saygın Abalı
Nur Canpolat
Gozde Yesil
Serap Turan
Abdullah Bereket
Tulay Guran
Publikationsdatum
20.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 1/2020
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-019-04329-0

Weitere Artikel der Ausgabe 1/2020

Pediatric Nephrology 1/2020 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.